...
首页> 外文期刊>Medicine. >Clinical outcome after a totally implantable venous access port-related infection in cancer patients: A prospective study and review of the literature
【24h】

Clinical outcome after a totally implantable venous access port-related infection in cancer patients: A prospective study and review of the literature

机译:癌症患者完全植入静脉通路相关感染后的临床结局:前瞻性研究和文献综述

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Morbidity and mortality after a totally implantable venous access port (TIVAP)-related infection in oncology patients have rarely been studied. We conducted this study to assess the incidence and factors associated with the following outcome endpoints: severe sepsis or septic shock at presentation, cancellation of antineoplastic chemotherapy, and mortality at week 12. We conducted a prospective single-center observational study including all adult patients with solid cancer who experienced a TIVAP-related infection between February 1, 2009, and October 31, 2010. Patients were prospectively followed for 12 weeks. Among 1728 patients receiving antineoplastic chemotherapy during the inclusion time, 72 had an episode of TIVAP-related infection (4.2%) and were included in the study (median age, 60 yr; range, 28-85 yr). The incidence of complications was 18% for severe sepsis or septic shock (13/72 patients), 30% for definitive cancellation of antineoplastic chemotherapy (14/46 patients who still had active treatment), and 46% for death at week 12 (33/72 patients). Factors associated with severe sepsis or septic shock were an elevated C-reactive protein (CRP) level and an infection caused by Candida species; 4 of the 13 severe episodes (31%) were due to coagulase-negative staphylococci (CoNS). Factors associated with death at week 12 were a low median Karnofsky score, an elevated Charlson comorbidity index, the metastatic evolution of cancer, palliative care, and an elevated CRP level at presentation. Hematogenous complications (that is, infective endocarditis, septic thrombophlebitis, septic pulmonary emboli, spondylodiscitis, septic arthritis, or organ abscesses) were found in 8 patients (11%). In conclusion, patients' overall condition (comorbidities and autonomy) and elevated CRP level were associated with an unfavorable clinical outcome after a TIVAP-related infection. Candida species and CoNS were responsible for severe sepsis or septic shock.
机译:很少研究肿瘤患者完全植入静脉通路(TIVAP)相关感染后的发病率和死亡率。我们进行了这项研究,以评估与以下结局指标有关的发生率和相关因素:就诊时出现严重败血症或败血性休克,取消抗肿瘤药化疗以及第12周的死亡率。我们进行了一项前瞻性单中心观察性研究,其中包括所有成年患者在2009年2月1日至2010年10月31日之间发生TIVAP相关感染的实体癌患者。预期对患者进行了12周的随访。在纳入期间接受抗肿瘤化学治疗的1728例患者中,有72例发生了与TIVAP相关的感染(4.2%),并被纳入研究(中位年龄60岁;范围28-85岁)。严重败血症或败血性休克并发症发生率为18%(13/72例),抗肿瘤化学疗法彻底取消的并发症发生率为30%(仍接受积极治疗的14/46例患者),第12周死亡的发生率为46%(33)。 / 72位患者)。与严重败血症或败血性休克相关的因素是C反应蛋白(CRP)水平升高和由念珠菌引起的感染。 13例严重发作中有4例(31%)是由于凝固酶阴性葡萄球菌(CoNS)引起的。与第12周时死亡相关的因素包括较低的Karnofsky中位数评分,Charlson合并症指数升高,癌症的转移演变,姑息治疗和就诊时CRP水平升高。在8例患者中发现了血源性并发症(即感染性心内膜炎,化脓性血栓性静脉炎,化脓性肺栓塞,脊椎盘炎,化脓性关节炎或器官脓肿)(11%)。总之,患者的整体状况(合并症和自主性)和CRP水平升高与TIVAP相关感染后不良的临床预后相关。念珠菌和CoNS导致严重的败血症或败血性休克。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号